These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2108058)
1. Transient hyperprolactinemia during cycle stimulation and its influence on oocyte retrieval and fertilization rates. Hummel WP; Clark MR; Talbert LM Fertil Steril; 1990 Apr; 53(4):677-81. PubMed ID: 2108058 [TBL] [Abstract][Full Text] [Related]
2. The metoclopramid-provocation test for prediction of transient hyperprolactinemia during cycle stimulation. Reinthaller A; Neunteufel W; Bieglmayer C; Fischl F Fertil Steril; 1990 Feb; 53(2):368-71. PubMed ID: 2298320 [TBL] [Abstract][Full Text] [Related]
3. [Effect of serum prolactin on cycle stimulation and fertilization of human oocytes]. Reinthaller A; Deutinger J; Csaicsich P; Riss P; Müller-Tyl E; Fischl F; Janisch H Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):246-8. PubMed ID: 3109998 [TBL] [Abstract][Full Text] [Related]
4. [Superovulation-induced transient hyperprolactinemia in human in vitro fertilization and embryo transfer]. Oda T; Yoshimura S; Hara T; Hara S; Yahagi M; Matsumoto C; Ohno T; Nakamura Y; Sumi Y; Sueoka K Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):113-20. PubMed ID: 3102646 [TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells. Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066 [TBL] [Abstract][Full Text] [Related]
6. Transient hyperprolactinemia during cycle stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment. Reinthaller A; Bieglmayer C; Deutinger J; Csaicsich P Fertil Steril; 1988 Mar; 49(3):432-6. PubMed ID: 3342894 [TBL] [Abstract][Full Text] [Related]
7. The influence of transient hyperprolactinemia on in vitro fertilization in humans. Forman R; Fishel SB; Edwards RG; Walters E J Clin Endocrinol Metab; 1985 Mar; 60(3):517-22. PubMed ID: 3919045 [TBL] [Abstract][Full Text] [Related]
8. Ovarian stimulation for in-vitro fertilization: clomiphene and HMG. Lehmann F; Baban N; Webber B Hum Reprod; 1988 Oct; 3 Suppl 2():11-21. PubMed ID: 3147988 [TBL] [Abstract][Full Text] [Related]
9. Effect of transitory hyperprolactinemia on in vitro fertilization of human oocytes. Mendes MC; Ferriani RA; Sala MM; Moura MD; Carrara HH; de Sá MF J Reprod Med; 2001 May; 46(5):444-50. PubMed ID: 11396370 [TBL] [Abstract][Full Text] [Related]
10. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile]. Sudik R; Fliess FR; Kunkel S Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795 [TBL] [Abstract][Full Text] [Related]
11. A novel ovarian stimulation protocol for use with the assisted reproductive technologies. Corfman RS; Milad MP; Bellavance TL; Ory SJ; Erickson LD; Ball GD Fertil Steril; 1993 Nov; 60(5):864-70. PubMed ID: 8224272 [TBL] [Abstract][Full Text] [Related]
12. [Correlation between serum prolactin secretion patterns and the ability of fertilization and cleavage of human oocyte (effects of transient hyperprolactinemia on fertilization and cleavage of human oocyte)]. Azuma K; Yamano S Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2097-106. PubMed ID: 4078410 [TBL] [Abstract][Full Text] [Related]
13. Oocyte retrieval for in vitro fertilization. Diedrich K; Van der Ven H; Al-Hasani S; Werner A; Krebs D Ann Biol Clin (Paris); 1987; 45(3):351-7. PubMed ID: 2959179 [TBL] [Abstract][Full Text] [Related]
14. A therapeutic role of prolactin supplementation in ovarian stimulation for in vitro fertilization: the bromocriptine-rebound method. Jinno M; Katsumata Y; Hoshiai T; Nakamura Y; Matsumoto K; Yoshimura Y J Clin Endocrinol Metab; 1997 Nov; 82(11):3603-11. PubMed ID: 9360514 [TBL] [Abstract][Full Text] [Related]
15. High progesterone/estradiol ratio in follicular fluid at oocyte aspiration for in vitro fertilization as a predictor of possible pregnancy. Basuray R; Rawlins RG; Radwanska E; Henig I; Sachdeva S; Tummon I; Binor Z; Dmowski WP Fertil Steril; 1988 Jun; 49(6):1007-11. PubMed ID: 3131157 [TBL] [Abstract][Full Text] [Related]
16. Number of follicles, oocytes and embryos in human in vitro fertilization is relative to serum estradiol and progesterone patterns during different types of ovarian hyperstimulation. Suchanek E; Huderer K; Dobec D; Hlavati V; Simunic V; Grizelj V Eur J Obstet Gynecol Reprod Biol; 1994 Aug; 56(2):121-7. PubMed ID: 7805963 [TBL] [Abstract][Full Text] [Related]
17. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome. Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830 [TBL] [Abstract][Full Text] [Related]
18. Minimum ovarian stimulation involving combined clomiphene citrate and estradiol treatment for in vitro fertilization of Bologna-criteria poor ovarian responders. Kuroda K; Kitade M; Kumakiri J; Jinushi M; Shinjo A; Ozaki R; Ikemoto Y; Katoh N; Takeda S J Obstet Gynaecol Res; 2016 Feb; 42(2):178-83. PubMed ID: 26555576 [TBL] [Abstract][Full Text] [Related]
19. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. Fried G; Remaeus K; Harlin J; Krog E; Csemiczky G; Aanesen A; Tally M J Assist Reprod Genet; 2003 May; 20(5):167-76. PubMed ID: 12812459 [TBL] [Abstract][Full Text] [Related]
20. Bromocriptine inhibition of anesthesia-induced hyperprolactinemia: effect on serum and follicular fluid hormones, oocyte fertilization, and embryo cleavage rates during in vitro fertilization. Sopelak VM; Whitworth NS; Norman PF; Cowan BD Fertil Steril; 1989 Oct; 52(4):627-32. PubMed ID: 2806601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]